PHBI — Pharmagreen Biotech Inc.

OTC · Industrials · Airlines · CIK 1435181 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.
No quarterly fundamentals indexed for this ticker.

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,002
EBITDA
Free Cash Flow
$-161,086
Enterprise Value
$1,034,781
Total Cash
$906
Total Debt
$352,411
Shares Out
691,345,739
Trailing EPS
$0.00
Book Value
$-0.00
ROE
ROA
-139.1%
Div Yield

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Sep 2022 0 -1,069,748 -875,478 208,971 2,031,620 -426,568
Sep 2021 0 -752,729 -4,532,071 373,081 2,065,781 -206,081

Peers — same industry

TickerNameMarket CapLastDaily %
FDX FEDEX CORP $95.44B $400.00
DAL DELTA AIR LINES, INC. $52.16B $79.39
UAL United Airlines Holdings, Inc. $34.38B $105.92
RYAAY RYANAIR HOLDINGS PLC $31.36B $60.29
LUV SOUTHWEST AIRLINES CO $20.67B $42.28

Recent Insider Activity

No insider activity indexed for this ticker.